News

Blog News

NC Commerce Secretary Sanders lays out state’s First in Talent plan at BMF meeting
News,
NC Commerce Secretary Sanders lays out state’s First in Talent plan at BMF meeting

NC Secretary of Commerce Machelle Sanders North Carolina Secretary of Commerce Machelle Baker Sanders encouraged the life sciences industry to be an active participant in shaping the state’s economic plan during the quarterly meeting of the NCBIO Biotech Manufacturer’s Forum held... Continue Reading

Date posted08/31/2021


NCBIO members inform state legislators at July Life Science Caucus meeting
News,
NCBIO members inform state legislators at July Life Science Caucus meeting

Representatives from G1 Therapeutics, United Therapeutics and Thermo Fisher Scientific shared insights from their companies with members of the North Carolina General Assembly's Life Science Caucus on during its meeting held Wednesday, July 21. Caucus co-chairs Sen. Mike Woodard, Sen.... Continue Reading

Date posted07/21/2021


NCBIO forum offers guidance on creating new lab space
News,
NCBIO forum offers guidance on creating new lab space

When it comes to creating lab space for a new or established business, getting your team together early and allowing plenty of time to plan are the keys to success, according to panelists assembled for NCBIO’s Lab Space Forum held online Tuesday, July 13. The pandemic has caused... Continue Reading

Date posted07/15/2021


Laura Gunter named new NCBIO president
News,
Laura Gunter named new NCBIO president

Laura Gunter Laura Gunter, M.B.A, has been selected as the new president of NCBIO, the N.C. Biosciences Organization, succeeding longtime president Sam Taylor who died in February. Gunter has served as the organization’s executive vice president since 2020 and has filled the executive... Continue Reading

Date posted07/8/2021


Vaccine patent waiver breaks faith with American companies, stifles innovation
News,
Vaccine patent waiver breaks faith with American companies, stifles innovation

Vaccine patent waiver breaks faith with American companies, stifles innovation NCBIO is extremely disappointed that the Biden administration has chosen to support waiving critical intellectual property protections for U.S. COVID-19 vaccines. This decision, known as a TRIPS waiver,... Continue Reading

Date posted05/13/2021